Identifying Promiscuous Compounds with Activity against Different Target Classes.
Christian Feldmann1, Filip Miljković1, Dimitar Yonchev1
1Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Endenicher Allee 19c, D-53115 Bonn, Germany.
Molecules (Basel, Switzerland)
|November 23, 2019
Summary
Researchers identified over 1000 promiscuous compounds active against multiple drug target classes. These multiclass ligands offer potential for polypharmacology and understanding molecular interactions, and are now publicly available.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Computational Biology
Background:
- Polypharmacology, utilizing compounds with multitarget activity, is crucial for modern drug discovery.
- Understanding how promiscuous compounds interact with diverse targets aids in developing novel therapeutics.
Purpose of the Study:
- To systematically identify compounds exhibiting activity against drug targets from different protein classes.
- To curate a collection of highly promiscuous compounds for pharmaceutical applications and molecular binding studies.
Main Methods:
- Analysis of public biological screening data, with careful exclusion of compounds prone to experimental artifacts.
- Identification and characterization of extensively assayed compounds, categorizing them by activity profiles (inactive, single-target, or promiscuous).
Main Results:
- Over 1000 multiclass ligands were identified, each active against 10 or more targets from different classes.
- Exemplary compounds were structurally validated through X-ray crystallography in complexes with distinct targets.
- A comprehensive dataset of promiscuous compounds was compiled, filtering out false positives.
Conclusions:
- The identified collection of multiclass ligands presents significant opportunities for drug discovery and understanding structure-activity relationships.
- Making these highly promiscuous compounds publicly available will accelerate research in polypharmacology and molecular interactions.
Related Concept Videos
Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K
Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K


